Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May;38(5):739-757.
doi: 10.1007/s11095-021-03037-5. Epub 2021 Apr 26.

Opportunities in an Evolving Pharmaceutical Development Landscape: Product Differentiation of Biopharmaceutical Drug Products

Andrea Allmendinger  1   2
Affiliations
Review

Opportunities in an Evolving Pharmaceutical Development Landscape: Product Differentiation of Biopharmaceutical Drug Products

Andrea Allmendinger. Pharm Res. 2021 May.

Abstract

The current perspective reviews the biopharmaceutical market until end of 2020 and highlights the transforming biopharmaceutical landscape during the recent decade. In particular, the rise of biosimilars and the development of new therapeutic modalities through recent advancement in molecular biology research sustainably change the product scenery. The present manuscript describes opportunities for pharmaceutical technical development, highlighting concepts such as product differentiation to succeed in a competitive product landscape. Product differentiation offers the opportunity for numerous life-cycle options and market exclusivity through incremental improvements in standard of care treatment. In particular, different formulation options and formulation-device combinations are described, focusing on systemic delivery of monoclonal antibody products and patient-centered development. The concept of product differentiation is exemplified in a case study about HER2+ breast cancer therapy, underlining pharmaceutical technical solutions and major improvements for the patient.

Keywords: biosimilar; co-formulation; combination products; drug delivery; product differentiation.

PubMed Disclaimer

References

    1. Morrison C. Fresh from the biotech pipeline-2019. Nat Biotechnol. 2020;38(2):126–31. - PubMed
    1. Muralidhara BK, Wong M. Critical considerations in the formulation development of parenteral biologic drugs. Drug Discov Today. 2020;25(3):574–81. - PubMed
    1. U.S. Food and Drug Admisnitration. Biologic License Application (BLA): 018780 Humulin. Last accessed: 2020 December 15. Available from: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview... .
    1. Morrison C. Fresh from the biotech pipeline-2018. Nat Biotechnol. 2019;37(2):118–23. - PubMed
    1. Morrison C. Fresh from the biotech pipeline-2017. Nat Biotechnol. 2018;36(2):131–6.

MeSH terms

LinkOut - more resources